Adaptive Biotechnologies (ADPT) Falls 24.5% as Execs Dispose Millions of Stake

5 days ago 5

Angelica Ballesteros

Mon, December 8, 2025 astatine 1:16 AM CST 2 min read

We precocious published December Disappointments: 10 Big Names Troubled Early. Adaptive Biotechnologies Corp. (NASDAQ:ADPT) is 1 of the worst performers of past week. Adaptive Biotechnologies fell by 24.5 percent week-on-week arsenic investors took way from 3 cardinal executives’ disposition of a important involvement successful the company. In abstracted regulatory filings past week, Adaptive Biotechnologies Corp. (NASDAQ:ADPT) said that Chairman and CEO Chad Robins, his elder brother, Harlan, who is presently main technological officer, arsenic good arsenic Chief Finance Officer Kyle Piskel, unloaded their portfolios successful the institution implicit the past fewer days.

Adaptive Biotechnologies (ADPT) Falls 24.5% arsenic  Execs Dispose Millions of Stake

Adaptive Biotechnologies (ADPT) Falls 24.5% arsenic Execs Dispose Millions of Stake

Tonhom1009/Shutterstock.com The younger Robins unsocial sold $3.07 cardinal of his shares done 2 rounds of stock income connected November 26 and December 1, with prices averaging $18.94 to $19.68 apiece. On November 28, Piskel followed with the merchantability of $3.17 cardinal of his shares, covering 162,820 astatine a terms of $19.5 apiece. However, helium besides acquired worthy $1.25 cardinal of caller shares astatine a terms of $6.55 to $12.14 apiece. Meanwhile, the elder Robins disposed of $672,515 worthy of shares successful the institution astatine a terms of $16.61 to $18.61 each. Adaptive Biotechnologies Corp. (NASDAQ:ADPT) said that the transactions were successful enactment with the Rule 10b5-1 trading program adopted successful August this year. Typically, mean investors presumption insider selling successful a antagonistic airy owed to concern concerns, though immoderate transactions are lone caused by profit-taking, diversification, and different idiosyncratic reasons, among others. While we admit the imaginable of ADPT arsenic an investment, our condemnation lies successful the content that immoderate AI stocks clasp greater committedness for delivering higher returns and person constricted downside risk. If you are looking for an highly inexpensive AI banal that is besides a large beneficiary of Trump tariffs and onshoring, spot our escaped study connected the best short-term AI stock.


Read Entire Article